Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study

Author
N. Simms-Williams
N. Treves
H. Yin
S. Lu
O. Yu
R. Pradhan
C. Renoux
S. Suissa
L. Azoulay
Keywords
Humans
*Sodium-Glucose Transporter 2 Inhibitors/therapeutic use/adverse effects
*Diabetes Mellitus, Type 2/drug therapy
Male
Female
*Glucagon-Like Peptide-1 Receptor/agonists
*Cardiovascular Diseases/prevention & control/epidemiology/mortality
Middle Aged
Aged
*Drug Therapy, Combination
Incidence
*Hypoglycemic Agents/therapeutic use/adverse effects
United Kingdom/epidemiology
Cohort Studies
Glucagon-like peptide-1 receptor agonists
Year of Publication
2024
Journal
Bmj
Volume
385
Number of Pages
e078242
ISBN Number
0959-8138 (Print)
0959-8138
Accession Number
38663919
DOI
10.1136/bmj-2023-078242